Image courtesy of EDDA Technology
November 25, 2015 — EDDA Technology announced that the company has received U.S. Food and Drug Administration (FDA) clearance on IQQA-Guide, a system that supports intra-operative precision 3-D navigation for surgical procedures of thoracic, abdominal and pelvic soft-organs.
IQQA-Guide is the latest addition to the IQQA Platform and Product Suite. It expands the IQQA precision 3-D imaging analytics into the operating room. Fully quantified and patient-specific IQQA anatomic models are extracted from multimodality images, and utilized for on-the-fly 3-D navigation to support physicians in "seeing through" organ surfaces and quantitatively referencing anatomies of interest in 3-D during surgery. Clinical studies (WICO 2015) suggest that IQQA-Guide may help reduce the use of intra-operative computed tomography (CT) scans during imaging-guided surgical procedures.
The treatment planning and follow-up assessment features provided by IQQA -BodyImaging, a part of the IQQA Platform, have already been widely used for liver, kidney and lung cancers. IQQA -BodyImaging has been proven to provide significant time-saving and improved patient care in more than 22,000 cases, according to the company.
For more information: www.eddatech.com
July 30, 2024 
